Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

NCT00007189 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2625

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Naproxen Sodium (Aleve)
DRUG: Celecoxib (Celebrex)

Sponsor

Seattle Institute for Biomedical and Clinical Research

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]